Guaifenesin Extended-release Tablet, Multilayer, Extended Release
Product Images NDC 68094-048

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Guaifenesin Extended-release (NDC 68094-048). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Precision Dose Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Principal Display Panel (600 mg Blister Pack Carton)

Principal Display Panel (600 mg Blister Pack Carton)
GuaiFENesin Extended-Release Tablets is an expectorant drug and comes in a Unique Bi-Layer Tablet. This drug is intended to help loosen phlegm and thin bronchial secretions to relieve congestion. The drug warnings suggest that it should not be given to children under 12 years of age and to consult a doctor for persistent or chronic cough. Moreover, the drug should not be taken along with alcohol or used during pregnancy or breastfeeding. It is Gluten-Free, and one pack of NDC 68094-048-61 consists of 100 Unit Dose Packages of 100 tablets (10x10) that are stored in between 20-25 degrees Celsius. Inactive ingredients are Carbomer homopolymer type B, FD&C blue #1 aluminum lake, hypromellose, magnesium stearate, microcrystalline cellulose, sodium starch glycolate. For any drug information, you can contact Precision Dose, Inc. by email or phone number provided in the packaging.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.